Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
Dietary lipids, gut microbiota and lipid metabolism
M Schoeler, R Caesar - Reviews in endocrine and metabolic disorders, 2019 - Springer
The gut microbiota is a central regulator of host metabolism. The composition and function of
the gut microbiota is dynamic and affected by diet properties such as the amount and …
the gut microbiota is dynamic and affected by diet properties such as the amount and …
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week
Observations on human and experimental atherosclerosis, biomarker studies, and now a
large-scale clinical trial support the operation of immune and inflammatory pathways in this …
large-scale clinical trial support the operation of immune and inflammatory pathways in this …
Immune dysfunction and risk of infection in chronic kidney disease
M Syed-Ahmed, M Narayanan - Advances in chronic kidney disease, 2019 - Elsevier
Cardiovascular disease and infections are directly or indirectly associated with an altered
immune response, which leads to a high incidence of morbidity and mortality, and together …
immune response, which leads to a high incidence of morbidity and mortality, and together …
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities–role of gut microbiota dysbiosis
Abstract Coronavirus disease 19 (COVID-19) is a pandemic condition caused by the new
coronavirus SARS-CoV-2. The typical symptoms are fever, cough, shortness of breath …
coronavirus SARS-CoV-2. The typical symptoms are fever, cough, shortness of breath …
Plant-dominant low-protein diet for conservative management of chronic kidney disease
K Kalantar-Zadeh, S Joshi, R Schlueter, J Cooke… - Nutrients, 2020 - mdpi.com
Chronic kidney disease (CKD) affects> 10% of the adult population. Each year,
approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis …
approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis …
Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation?
H Fukui - Inflammatory intestinal diseases, 2016 - karger.com
Background: Increased intestinal permeability due to barrier dysfunction is supposed to
cause microbial translocation which may induce low-grade inflammation in various …
cause microbial translocation which may induce low-grade inflammation in various …
The gut microbiome, kidney disease, and targeted interventions
A Ramezani, DS Raj - Journal of the American Society of …, 2014 - journals.lww.com
The human gut harbors> 100 trillion microbial cells, which influence the nutrition,
metabolism, physiology, and immune function of the host. Here, we review the quantitative …
metabolism, physiology, and immune function of the host. Here, we review the quantitative …
The role of gut microbiota in atherosclerosis and hypertension
J Ma, H Li - Frontiers in pharmacology, 2018 - frontiersin.org
In recent years, accumulating evidence has indicated the importance of gut microbiota in
maintaining human health. Gut dysbiosis is associated with the pathogenesis of a number of …
maintaining human health. Gut dysbiosis is associated with the pathogenesis of a number of …
The immune system and kidney disease: basic concepts and clinical implications
C Kurts, U Panzer, HJ Anders, AJ Rees - Nature Reviews Immunology, 2013 - nature.com
The kidneys are frequently targeted by pathogenic immune responses against renal
autoantigens or by local manifestations of systemic autoimmunity. Recent studies in rodent …
autoantigens or by local manifestations of systemic autoimmunity. Recent studies in rodent …